Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
KAKEN Pharmaceutical is a leading Japanese pharmaceutical company specializing in the development of innovative medicines. Its primary focus lies in the fields of dermatology, orthopedics, and wound healing. Furthermore, KAKEN provides high-quality solutions in medical research and development.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
KAKEN Pharmaceutical is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
KAKEN Pharmaceutical last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 222.86 JPY.
Across its last 3 earnings reports, KAKEN Pharmaceutical stock moved by ±0.9% on average the following day. The largest reaction was +1.5% on 02/06/2025; 1 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.